Vascular Biogenics Ltd.(NASDAQ : VBLT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||1.43%||213.38||1.9%||$524.90m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.20%||457.50||2.7%||$521.71m|
|GILD||Gilead Sciences, Inc.||1.73%||63.54||1.0%||$487.81m|
|BNGO||Bionano Genomics, Inc.||-1.37%||9.71||0.0%||$358.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.51%||151.19||2.0%||$356.41m|
|CRSP||CRISPR Therapeutics AG||0.12%||130.41||0.6%||$309.94m|
|EXAS||EXACT Sciences Corp.||-1.57%||138.02||18.4%||$258.28m|
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.